Literature DB >> 25409576

New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial.

J S Renes1, R H Willemsen1, J C Mulder2, W M Bakker-van Waarde3, J Rotteveel4, W Oostdijk5, E C A M Houdijk6, C Westerlaken7, C Noordam8, A A Verrijn Stuart9, R J Odink10, M A J de Ridder11, A C S Hokken-Koelega1,12.   

Abstract

BACKGROUND: Growth hormone (GH) treatment is effective in improving adult height (AH) in short children born SGA. However, there is a wide variation in height gain, even after adjustment for predictive variables. It is therefore important to investigate new factors which can influence the response to GH.
OBJECTIVE: To investigate the efficacy of GH treatment (1 mg/m(2/) day) in short SGA children on AH. To assess the relation between spontaneous catch-up growth after birth and growth during puberty on the total height gain SDS to AH. PATIENTS: Longitudinal GH trial in 170 children.
RESULTS: Median age at start of GH was 7·1 years and height -3·0 SDS. AH was -1·8 SDS (TH-corrected AH -1·1 SDS) in boys and -1·9 SDS (TH-corrected AH -1·3 SDS) in girls. Spontaneous catch-up growth after birth was ≥0·5 SDS in 42% of children. In contrast to expectation, spontaneous catch-up growth was negatively correlated with total height gain SDS during GH (P = 0·009). During puberty, height SDS declined (-0·4 SDS in boys and -0·5 SDS in girls) resulting in a lower total height gain SDS than expected. Pubertal height gain was 25·5 cm in boys and 15·3 cm in girls, significantly lower compared to AGA children (P < 0·001). At onset of puberty, BA for boys and girls was moderately advanced (P = 0·02 and P < 0·001, respectively). Growth velocity was comparable to AGA children during the first two years of puberty, but thereafter significantly lower until reaching AH (P < 0·001).
CONCLUSION: In contrast to our hypothesis, children with greater spontaneous catch-up growth after birth show a lower total height gain SDS during GH. Height SDS declines from mid-puberty, due to a marked early deceleration of growth velocity.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25409576     DOI: 10.1111/cen.12677

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

Review 1.  Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age.

Authors:  Judith S Renes; Jaap van Doorn; Anita C S Hokken-Koelega
Journal:  Horm Res Paediatr       Date:  2019-09-11       Impact factor: 2.852

2.  Factors influencing height gain in children born small for gestational age treated with recombinant growth hormone: what extent is puberty involved?

Authors:  Ramón Arroyo Ruiz; Aránzazu Ballester Pérez; Isabel Leiva-Gea; MªJosé Martínez-Aedo; Juan Pedro López-Siguero
Journal:  Ther Adv Endocrinol Metab       Date:  2022-04-02       Impact factor: 3.565

3.  Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.

Authors:  Dalia Al-Abdulrazzaq; Abdullah Al-Taiar; Kholoud Hassan; Iman Al-Basari
Journal:  BMC Endocr Disord       Date:  2015-12-03       Impact factor: 2.763

4.  Retrospective longitudinal analysis of the effects of postnatal weight gain on the timing and tempo of puberty and menarche in a cohort of Italian girls.

Authors:  Vittorio Ferrari; Simona Stefanucci; Marta Ferrari; Daniele Ciofi; Stefano Stagi
Journal:  Ital J Pediatr       Date:  2022-02-03       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.